Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) Plans $0.41 Annual Dividend

Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) declared an annual dividend on Monday, December 29th. Shareholders of record on Tuesday, December 30th will be paid a dividend of 0.4132 per share on Wednesday, December 31st. This represents a yield of 159.0%. The ex-dividend date is Tuesday, December 30th.

Amplify Weight Loss Drug & Treatment ETF Stock Down 0.7%

NYSEARCA THNR opened at $25.94 on Tuesday. The firm has a market capitalization of $2.85 million, a P/E ratio of 24.31 and a beta of 0.61. The company has a 50-day moving average price of $24.76 and a 200-day moving average price of $23.72. Amplify Weight Loss Drug & Treatment ETF has a 52 week low of $18.56 and a 52 week high of $26.30.

Amplify Weight Loss Drug & Treatment ETF Company Profile

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.